Neonc Technologies (NASDAQ:NTHI) CEO Amir Heshmatpour Buys 50,000 Shares of Company Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour acquired 50,000 shares of the business’s stock in a transaction dated Tuesday, November 10th. The shares were bought at an average cost of $4.19 per share, with a total value of $209,500.00. Following the transaction, the chief executive officer directly owned 3,313,000 shares of the company’s stock, valued at $13,881,470. The trade was a 1.53% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link.

Neonc Technologies Trading Up 7.3%

NASDAQ NTHI opened at $4.85 on Friday. Neonc Technologies Holdings, Inc. has a twelve month low of $2.50 and a twelve month high of $11.81. The firm has a 50-day simple moving average of $3.30 and a 200 day simple moving average of $5.29.

Neonc Technologies (NASDAQ:NTHI) last issued its quarterly earnings results on Thursday, November 5th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.03).

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. BTIG Research restated a “buy” rating and set a $15.00 price objective on shares of Neonc Technologies in a research report on Tuesday, September 8th. Zacks Research upgraded shares of Neonc Technologies from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 5th. Roth Capital initiated coverage on shares of Neonc Technologies in a research note on Thursday, September 24th. They set a “buy” rating on the stock. Wall Street Zen raised shares of Neonc Technologies from a “sell” rating to a “hold” rating in a report on Saturday, November 7th. Finally, Weiss Ratings cut shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, October 21st. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Neonc Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Institutional Investors Weigh In On Neonc Technologies

A number of institutional investors have recently added to or reduced their stakes in NTHI. Global Retirement Partners LLC bought a new stake in shares of Neonc Technologies in the 2nd quarter valued at approximately $126,000. BlackRock Inc. bought a new position in shares of Neonc Technologies during the 2nd quarter worth approximately $815,000. Westmount Partners LLC lifted its position in shares of Neonc Technologies by 355.2% during the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after buying an additional 153,858 shares during the period. Finally, Bank of America Corp DE bought a new position in shares of Neonc Technologies during the 2nd quarter worth approximately $1,017,000.

About Neonc Technologies

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.